Suppr超能文献

血小板活化因子对人嗜酸性粒细胞脱颗粒的刺激作用。

Stimulation of degranulation from human eosinophils by platelet-activating factor.

作者信息

Kroegel C, Yukawa T, Dent G, Venge P, Chung K F, Barnes P J

机构信息

Department of Thoracic Medicine, National Heart and Lung Institute, London, United Kingdom.

出版信息

J Immunol. 1989 May 15;142(10):3518-26.

PMID:2541198
Abstract

Platelet-activating factor (PAF) is a highly active mediator which has been implicated in allergic inflammation and bronchial asthma, possibly by interacting with eosinophils. We have examined the effect of PAF on activation of purified human eosinophils as measured by degranulation (eosinophil peroxidase, eosinophil cationic protein, arylsulfatase B, beta-glucuronidase, and alkaline phosphatase) and oxidative metabolism (superoxide anion production). PAF induced enzyme release at concentrations ranging from 1 pM to 10 microM in a rapid (t1/2 5 to 8 min), Ca2+-dependent and noncytotoxic manner from both the specific and small granules, whereas its biologic precursor and metabolite, lyso-PAF, had no effect. For all enzymes, maximal enzyme release occurred at 100 nM PAF with a mean ED50 value of 1.47 +/- 0.4 nM. At this concentration the mean percentage of total enzyme release by PAF from specific granules was 20.3 +/- 1.6% (17.9% for eosinophil peroxidase, 20.6% for beta-glucuronidase, 22.4% for alkaline phosphatase) and 28.8 +/- 2.2% from small granules (arylsulfatase B). Calcium ionophore A23187, PMA, and opsonized zymosan also induced eosinophil degranulation but their peak effect after 10-min incubation with maximal release 14.7%, 12.9%, or 14.1%, respectively, was lower when compared with PAF. Incubation of eosinophils with the PAF-antagonist WEB 2086 led to a parallel shift of the dose-response curve to the right, indicating a competitive antagonism. PAF also caused generation of superoxide anions by human eosinophils but this occurred at higher concentrations of PAF (1 microM to 30 microM) with an ED50 of 8.4 +/- 0.9 microM. Again, this effect was competitively inhibited by WEB 2086. These studies demonstrate that PAF activates human eosinophils to release granule constituents and generate superoxide anions. Since both PAF and eosinophil products are associated with pathogenesis of bronchial asthma our findings may be of particular pathophysiologic relevance.

摘要

血小板活化因子(PAF)是一种高活性介质,可能通过与嗜酸性粒细胞相互作用而参与过敏性炎症和支气管哮喘。我们研究了PAF对纯化的人嗜酸性粒细胞活化的影响,通过脱颗粒(嗜酸性粒细胞过氧化物酶、嗜酸性粒细胞阳离子蛋白、芳基硫酸酯酶B、β-葡萄糖醛酸酶和碱性磷酸酶)和氧化代谢(超氧阴离子产生)来衡量。PAF以快速(t1/2为5至8分钟)、钙依赖性且无细胞毒性的方式,在1 pM至10 μM的浓度范围内诱导特异性颗粒和小颗粒中的酶释放,而其生物前体和代谢产物溶血PAF则无作用。对于所有酶,在100 nM PAF时出现最大酶释放,平均ED50值为1.47±0.4 nM。在此浓度下,PAF从特异性颗粒中释放的总酶平均百分比为20.3±1.6%(嗜酸性粒细胞过氧化物酶为17.9%,β-葡萄糖醛酸酶为20.6%,碱性磷酸酶为22.4%),从小颗粒(芳基硫酸酯酶B)中释放的为28.8±2.2%。钙离子载体A₂₃₁₈₇、佛波醇酯(PMA)和调理酵母聚糖也诱导嗜酸性粒细胞脱颗粒,但与PAF相比,它们在孵育10分钟后的峰值效应(最大释放分别为14.7%、12.9%或14.1%)较低。用PAF拮抗剂WEB 2086孵育嗜酸性粒细胞导致剂量反应曲线平行右移,表明存在竞争性拮抗作用。PAF还可导致人嗜酸性粒细胞产生超氧阴离子,但这发生在较高浓度的PAF(1 μM至30 μM)下,ED50为8.4±0.9 μM。同样,这种效应被WEB 2086竞争性抑制。这些研究表明,PAF可激活人嗜酸性粒细胞释放颗粒成分并产生超氧阴离子。由于PAF和嗜酸性粒细胞产物均与支气管哮喘的发病机制相关,我们的发现可能具有特殊的病理生理学意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验